NFKB1 and breast carcinoma: Activated NF-κB homo- or heterodimers translocate into the nucleus, alone or with other transcription factors, and activate downstream genes, thereby regulating survival, inflammation, the immune system, and the proliferation and metastasis of mammary carcinoma, which may be a useful strategy for inhibiting tumour malignancy 41-43.